Variation in assistive technology use in Motor Neuron Disease according to clinical phenotypes and ALS Functional Rating Scale - Revised Score: A prospective observational study.

CONCLUSIONS: Clinicians need to consider MND phenotype and/or ALSFRS-R domain sub-score in clinical decision-making regarding assistive technology, as this will determine the pattern of disease and its progression, and hence assistive technology required. PMID: 31006691 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31006691?dopt=Abstract

Source: NeuroRehabilitation - April 23, 2019 Category: Rehabilitation Tags: NeuroRehabilitation Source Type: research